Introduction
Continued expression were found almost exclusively amidst the CD4
ϩ CD25 ϩ compartment of thymocytes and peripheral Treg [2] [3] [4] [5] [6] .
It is now known that Tregs play a critical role in the induction of tolerance to self-antigens, including those expressed by tumours. Recently, published findings have shown that immune regulation mediated by Treg, which is vital for preventing autoimmunity, represents a mechanism whereby the efficient antitumour response is inhibited [4, 7] .
It was described that Treg frequency is increased in the peripheral circulation of patients with different types of tumours, and their accumulation in the tumour microenvironment may be a negative prognostic factor for some types of malignancies [8] [9] [10] [11] . An increase in the number of T-regulatory lymphocytes in the peripheral circulation and at the tumour site has also been shown to correlate with progression of head and neck squamous cell carcinoma (HNSCC) [12] [13] [14] . [15, 16] . [17] .
Not only does increase in T-regulatory cell number interfere with the antitumour immune response, but at the same time, Treg cells may be the main obstacle undermining anti-cancer immunotherapy and active vaccination

Although significant advances in the treatment regimen for patients with HNSCC have been documented within the last 20 years, regrettably, survival rates for this disease have not improved for many years
Thus, the development of new molecular markers, which could help to describe the biological and immunological status of patients and predict disease progression, may help with selecting the appropriate treatment modalities for individual patients [18] [19] [20] [21] . (Fig. 2) . (Fig. 3) . (Fig. 3) .
Patients and methods
HNSCC patients
Healthy volunteers -blood donors
Levels of Treg were evaluated based on differentiation of tumour cells according to histological grading (G stage, G1 versus G2 versus G3ϩ4). There were no significant differences in levels of Treg (14.85% versus 15.84% versus 14.25%). In other subgroups of lymphocytes, differences in levels of cytotoxic T lymphocytes
Fig. 1 Comparison of Treg and other lymphocyte subpopulations in patients with HNSCC (head and neck squamous cell carcinoma) with those of healthy blood donors (C). (A) -regulatory T lymphocytes (CD3
Fig. 2 Statistically significant parameters that are in a positive correlation with the size of the tumour (T stage). (A) -naïve T lymphocytes (CD45RA
ϩ CD4 ϩ );
(B) -SCC ϭ squamous cell carcinoma antigen; (C) -CRP ϭ C-reactive protein; (D) -AAT ϭ ␣-1-antitrypsin; (E) -
The [25] [26] [27] . An increase in T-regulatory cells in the peripheral circulation and at the tumour site was previously reported in patients with HNSCC, and these results seem to be in agreement with the majority of published data for other human cancers [8, 12, [28] [29] [30] . In addition, a positive association with infiltration by Treg and better locoregional control of the tumour or longer diseasefree interval was also reported [31] .
Fig. 3 Statistically significant parameters that are in a correlation with the spread of tumour to the regional lymphatic nodes (N stage) and with differentiation of tumour cells (Grade). (A) -B cells (CD45ϩCD3-CD19ϩ); (B) -Cyfra 21-1; (C) -CRP ϭ C-reactive protein; (D) -Tc cells (CD3
The data for this study were collected over more than 3 [32, 33] .
NK cells play one of the pivotal roles in antitumour immunity. Recently, it was published that NK cell numbers are reduced in the peripheral blood of cancer patients, and that a severe deficiency in circulating NK cells was related to the poor clinical outcome in HNSCC patients [34] [38] .
Tumour production of growth factors and the immunological reaction within the tumour microenvironment causes mobilization of precursor cells with subsequent migration to the periphery and tumour site [39] 
